Tyring, Stephen K. http://orcid.org/0000-0002-3337-0580
Rich, Phoebe
Tada, Yayoi
Beeck, Stefan
Messina, Izabella
Liu, Jie
Huang, Xiaohong
Shumack, Stephen http://orcid.org/0000-0002-9121-7795
Clinical trials referenced in this document:
Documents that mention this clinical trial
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
https://doi.org/10.1007/s13555-022-00876-x
Funding for this research was provided by:
AbbVie
Article History
Received: 14 October 2022
Accepted: 7 December 2022
First Online: 2 January 2023